Bruce Jackson
Stock Analyst at Benchmark Co.
(0.08)
# 4,651
Out of 4,692 analysts
302
Total ratings
36.9%
Success rate
-9.3%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNCY Unicycive Therapeutics | Maintained: Buy | $13 → $15 | $5.20 | +188.46% | 12 | Aug 20, 2026 | |
| PODD Insulet | Maintained: Buy | $250 → $185 | $148.66 | +24.45% | 2 | Aug 6, 2026 | |
| DXCM DexCom | Maintained: Buy | $77 → $82 | $91.06 | -9.95% | 2 | Jul 31, 2026 | |
| NEO NeoGenomics | Maintained: Buy | $11 → $16 | $17.91 | -10.66% | 24 | Jul 24, 2026 | |
| MMED MiniMed Group | Maintained: Buy | $20 | $20.26 | -1.28% | 2 | Jun 3, 2026 | |
| HUMA Humacyte | Maintained: Buy | $1 → $2 | $0.6014 | +232.56% | 23 | Jun 1, 2026 | |
| BFRI Biofrontera | Maintained: Buy | $3 | $1.53 | +96.08% | 20 | May 19, 2026 | |
| TNDM Tandem Diabetes Care | Initiated Coverage: Hold | n/a | $22.01 | - | 1 | May 11, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | $145 → $120 | $110.36 | +8.74% | 4 | Apr 17, 2026 | |
| CV CapsoVision | Maintained: Buy | $14 → $10 | $5.84 | +71.23% | 5 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $20 | $2.62 | +664.82% | 11 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $6 | $8.11 | -26.02% | 18 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $187 → $217 | $155.71 | +39.36% | 21 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $4.28 | +624.30% | 18 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.25 → $1 | $0.4768 | +109.73% | 6 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.6761 | - | 20 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.4339 | - | 14 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $280 → $140 | $0.48 | +29,066.67% | 4 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.76 | n/a | 6 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3 | $0.6875 | n/a | 6 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.35 → $2 | $1.87 | n/a | 6 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $24 | $4.53 | n/a | 4 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1 | $0.423 | n/a | 1 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $0.4 | $0.0001 | n/a | 6 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $960 → $240 | $0.0001 | n/a | 8 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $22.59 | n/a | 15 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $5 | $3.92 | n/a | 13 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.9087 | n/a | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $4 | $3.15 | n/a | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.35 | n/a | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $5.98 | n/a | 3 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $1.29 | n/a | 1 | Jul 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $0.318 | n/a | 3 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $38 | $50.76 | n/a | 5 | Mar 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.54 | n/a | 5 | Feb 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.10 | n/a | 1 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 → $92 | $16.92 | n/a | 2 | Oct 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 | $90.65 | n/a | 2 | Nov 21, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $48.30 | n/a | 2 | Mar 2, 2012 |
Unicycive Therapeutics
Aug 20, 2026
Maintained: Buy
Price Target: $13 → $15
Current: $5.20
Upside: +188.46%
Insulet
Aug 6, 2026
Maintained: Buy
Price Target: $250 → $185
Current: $148.66
Upside: +24.45%
DexCom
Jul 31, 2026
Maintained: Buy
Price Target: $77 → $82
Current: $91.06
Upside: -9.95%
NeoGenomics
Jul 24, 2026
Maintained: Buy
Price Target: $11 → $16
Current: $17.91
Upside: -10.66%
MiniMed Group
Jun 3, 2026
Maintained: Buy
Price Target: $20
Current: $20.26
Upside: -1.28%
Humacyte
Jun 1, 2026
Maintained: Buy
Price Target: $1 → $2
Current: $0.6014
Upside: +232.56%
Biofrontera
May 19, 2026
Maintained: Buy
Price Target: $3
Current: $1.53
Upside: +96.08%
Tandem Diabetes Care
May 11, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $22.01
Upside: -
Abbott Laboratories
Apr 17, 2026
Maintained: Buy
Price Target: $145 → $120
Current: $110.36
Upside: +8.74%
CapsoVision
Mar 27, 2026
Maintained: Buy
Price Target: $14 → $10
Current: $5.84
Upside: +71.23%
Mar 20, 2026
Maintained: Buy
Price Target: $23 → $20
Current: $2.62
Upside: +664.82%
Mar 16, 2026
Maintained: Buy
Price Target: $20 → $6
Current: $8.11
Upside: -26.02%
Mar 3, 2026
Maintained: Buy
Price Target: $187 → $217
Current: $155.71
Upside: +39.36%
Dec 3, 2025
Reiterated: Buy
Price Target: $31
Current: $4.28
Upside: +624.30%
Nov 20, 2025
Maintained: Buy
Price Target: $1.25 → $1
Current: $0.4768
Upside: +109.73%
Nov 7, 2025
Maintained: Hold
Price Target: n/a
Current: $0.6761
Upside: -
Sep 15, 2025
Maintained: Hold
Price Target: n/a
Current: $0.4339
Upside: -
Sep 15, 2025
Maintained: Buy
Price Target: $280 → $140
Current: $0.48
Upside: +29,066.67%
Nov 26, 2024
Reiterated: Buy
Price Target: $8
Current: $3.76
Upside: n/a
Oct 11, 2024
Reiterated: Buy
Price Target: $5 → $3
Current: $0.6875
Upside: n/a
Jun 6, 2024
Maintained: Buy
Price Target: $1.35 → $2
Current: $1.87
Upside: n/a
Apr 15, 2024
Maintained: Buy
Price Target: $40 → $24
Current: $4.53
Upside: n/a
Apr 8, 2024
Initiated Coverage: Buy
Price Target: $1
Current: $0.423
Upside: n/a
Mar 22, 2024
Maintained: Buy
Price Target: $4 → $0.4
Current: $0.0001
Upside: n/a
Sep 21, 2023
Maintained: Buy
Price Target: $960 → $240
Current: $0.0001
Upside: n/a
Sep 15, 2023
Downgraded: Hold
Price Target: n/a
Current: $22.59
Upside: n/a
Aug 24, 2023
Maintained: Buy
Price Target: $9 → $5
Current: $3.92
Upside: n/a
Jul 21, 2023
Initiated Coverage: Buy
Price Target: $5
Current: $0.9087
Upside: n/a
Mar 23, 2023
Maintained: Buy
Price Target: $8 → $4
Current: $3.15
Upside: n/a
Mar 22, 2023
Reiterated: Buy
Price Target: $6
Current: $0.35
Upside: n/a
Jun 29, 2021
Maintained: Buy
Price Target: $8
Current: $5.98
Upside: n/a
Jul 20, 2018
Initiated Coverage: Buy
Price Target: $27
Current: $1.29
Upside: n/a
Apr 5, 2018
Reiterated: Buy
Price Target: $42
Current: $0.318
Upside: n/a
Mar 2, 2018
Reiterated: Buy
Price Target: $26 → $38
Current: $50.76
Upside: n/a
Feb 26, 2018
Downgraded: Hold
Price Target: n/a
Current: $4.54
Upside: n/a
Feb 2, 2018
Initiated Coverage: Buy
Price Target: $8
Current: $1.10
Upside: n/a
Oct 28, 2016
Upgraded: Buy
Price Target: $40 → $92
Current: $16.92
Upside: n/a
Nov 21, 2012
Maintained: Hold
Price Target: $46
Current: $90.65
Upside: n/a
Mar 2, 2012
Initiated Coverage: Buy
Price Target: n/a
Current: $48.30
Upside: n/a